News Focus
News Focus
icon url

dodah_2

10/16/08 7:12 PM

#14539 RE: go seek #14537

What do lowly stockholders say when it's announced that JNJ is buying GTCB for 6.95 per share in an all stock deal?
icon url

go seek

10/16/08 10:57 PM

#14541 RE: go seek #14537

;) What is Eisai-North America announces $193M deal
for ATryn rights in Japan, with $30M in upfront cash?

icon url

fogbottom

10/18/08 12:55 PM

#14565 RE: go seek #14537

OK... here's the Jeopardy answer of the day?

GTCB HITS IT OUT OF THE PARK (PHARM)... a HOMERUN!

What is the headline?
Don't forget to answer in the form of a question or you lose.
--------------------------------------------------------------

What is...The FDA today announced the approval of Atryn for hereditary antithrombin deficiency and also announced that since Atryn, being a protein, is not really a drug and is so close chemically to naturally occuring ATIII, that it doesn't need to undergo further testing and approval for all the multitude of uses that studies have proven AtIII to be beneficial for?